Trials / Recruiting
RecruitingNCT07165223
A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 300 (estimated)
- Sponsor
- Gan & Lee Pharmaceuticals. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted to compare the efficacy, safety and patient-reported outcome of GZR4 and Insulin Icodec with or without Non-Insulin Antidiabetic Agents in subjects with Type 2 Diabetes Mellitus (T2DM) treated with basal insulin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GZR4 | GZR4 s.c., once-weekly，treat-to-target dose |
| DRUG | Insulin Icodec group | insulin Icodec s.c., once-weekly，treat-to-target dose |
Timeline
- Start date
- 2025-10-17
- Primary completion
- 2026-11-10
- Completion
- 2026-11-10
- First posted
- 2025-09-10
- Last updated
- 2025-11-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07165223. Inclusion in this directory is not an endorsement.